Table 1:
TSH and T4L levels during nivolumab and ipilimumab treatment.
Week 0
Week 3
Week 5
Week 8
Week 11
TSH (mU/L)
0.978
0.982
0.0012
0.144
0.846
T4L (ng/dl)
0.87
0.89
3.60
0.77
0.82